This site contains promotional information intended only for healthcare professionals resident in the United Kingdom

Visit Pfizer Medical site
Search

Menu

Close

Sign In or RegisterLog Out
Pfizer MedicinesTherapy AreasExplore ContentEventsVideosMaterialsFeatured ArticlesLet’s ConnectSupplyAlliance HealthcareOff-contract claims

Example content

Adverse event reporting can be found at the bottom of the page

Comprehensive Migraine Management: Integrating Targeted Therapies

Prescribing information can be found at the bottom of the page


Join us on 18 June 2025 to hear from Professor Manjit Matharu, Consultant Neurologist & Headache Service Lead and Dr Tim Yates, Consultant Neurologist discussing 'Comprehensive Migraine Management: Integrating Targeted Therapies' followed by a live interactive Q&A.

This promotional meeting is organised and funded by Pfizer Ltd for UK HCPs and will include reference to medicines promoted by Pfizer.

Prescribing information can be found at the bottom of the page


Join us on 18 June 2025 to hear from Professor Manjit Matharu, Consultant Neurologist & Headache Service Lead and Dr Tim Yates, Consultant Neurologist discussing 'Comprehensive Migraine Management: Integrating Targeted Therapies' followed by a live interactive Q&A.

This promotional meeting is organised and funded by Pfizer Ltd for UK HCPs and will include reference to medicines promoted by Pfizer.

Event Date18 June 2025 13:00 BSTDuration1 Hr 15 AudienceConsultants, General practitioners, Nurses, Pharmacists, Specialist Registrars {{givenName}}%20{{familyName}}%20has%20shared%20a%20resource%20with%20you%3B%20please%20click%20the%20link%20below%3A%0D%0A%0D%0A{{URL}}%0D%0A%0D%0AThank%20you%2C%0D%0A{{givenName}}%20{{familyName}}
Agenda
Meeting Agenda 12:50 - 13:00Joining & Registration
13:00 - 14:00Comprehensive Migraine Management: Integrating Targeted Therapies Manjit Matharu - Professor Tim Yates - Dr
14:00 - 14:15Questions & Answers Manjit Matharu - Professor Tim Yates - Dr
14:15Meeting Close
Speakers
Event Speakers
Manjit Matharu, Professor
Manjit Matharu, ProfessorConsultant Neurologist & Headache Service Lead, The National Hospital for Neurology and Neurosurgery

Professor Matharu trained at The University of Manchester and completed his general medical training in London leading up to obtaining the MRCP in 1998. He subsequently obtained a PhD at The UCL Institute of Neurology, Queen Square, London. He completed his residency in Neurology at The National Hospital for Neurology and Neurosurgery, The Royal London Hospital and Homerton Hospital in London in 2007 before taking up his current post. Professor Matharu is a member of the Headache and Pain subcommittee of the Association of British Neurologists. He was a member of the National Institute for Health and Clinical Excellence (NICE) guideline development group (GDG) for Headache Disorders.

Tim Yates, Dr
Tim Yates, DrConsultant Neurologist, The National Hospital of Neurology and Neurosurgery

Dr Tim Yates has been a Consultant Neurologist at the North Middlesex University Hospital NHS Trust, and Honorary Consultant at the National Hospital for Neurology and Neurosurgery in the Headache and Facial Pain Group, since 2021. After qualifying with distinction from Cambridge, Tim trained at Addenbrooke’s and then in London at University College Hospital, with higher clinical and academic training in neurology at Queen Square and the Royal Free. Tim sees inequality as a contributor to the development of chronic migraine and headache morbidity in general. He is looking to develop a specialist headache service at the North Middlesex, which serves one of the UK’s most deprived areas. As Trust Chief Medical Information Officer, with a long-standing interest in clinical informatics, he is examining how modern population health data approaches can reduce inequalities in headache care.

Vydura®(rimegepant) 

Prescribing Information

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search for MHRA Yellow Card in Google Play or Apple App Store. Adverse events should also be reported to Pfizer Medical Information on 01304 616161.

PP-NNT-GBR-2872. April 2025

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search 

for MHRA Yellow Card in Google Play or Apple App Store

 

Adverse events should also be reported to Pfizer Medical Information on 01304 616161

PfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign In or RegisterAccountSign Out

This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc

 

This website is brought to you by Pfizer Limited, a company registered in England 

and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ

 

Copyright © 2025 Pfizer Limited. All rights reserved.

 

VAT registration number GB201048427

PP-UNP-GBR-11245. January 2025
For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-UNP-GBR-7812. January 2024.

YesNo
You are now leaving PfizerPro​​​​​

You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site.​​​​​​​​​​​​​​

​​​​​​​PP-PFE-GBR-3858. November 2021​​​​​​​
​​​​​​​
You are now leaving PfizerPro
​​​​​​​
​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site other than the information or other materials relating to ​​​​​Pfizer medicines or 
business which it has provided or reviewed.

PP-PFE-GBR-3859. November 2021
​​​​​​​